urothelial carcinoma: ev-301 update from asco 2022
Published 2 years ago • 234 plays • Length 8:27Download video MP4
Download video MP3
Similar videos
-
12:58
treatment of advanced urothelial carcinoma – a discussion of ev-301
-
0:44
ev-301 trial: treatment for metastatic bladder cancer | russell pachynski, md | asco22 updates
-
0:39
bladder cancer highlights at asco 2022
-
1:10
highlights in bladder cancer from asco 2022
-
5:40
highlights in bladder cancer from asco gu 2021
-
4:22
checkmate 274 & ev-301: highlights in uc from asco gu
-
21:40
bladder cancer conference highlights from asco 2022
-
0:37
bladder-sparing approaches in muscle-invasive urothelial carcinoma
-
0:58
replacing the current standard of care for urothelial carcinoma
-
2:01
matthew galsky, md, tells us about the design and outcomes of the ev-301 trial from asco gu '21
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
1:06
key trials in bladder cancer from asco gu 2022
-
1:21
bladder cancer at asco 2022: rc48 vedotin, chemoimmunotherapy
-
23:23
video series - urothelial carcinoma: management of ev aes - chapter 3: peripheral neuropathy
-
1:34
phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
-
1:14
what is bladder cancer?
-
1:01
unc health talk: bladder cancer
-
0:41
unmet clinical needs for muscle-invasive bladder cancer
-
46:31
management of urothelial carcinoma of the upper urinary tract